Skip to main content
OpenTrials

Clinical trial condition

Acellular Pertussis

Explore clinical trials studying Acellular Pertussis. Study availability and eligibility vary by location and protocol.

64 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Acellular Pertussis trial results

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Novara, Piedmont, Italy
  • GSK Investigational Site Cagliari, Sardinia, Italy
View Trial Details
Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

NCT01738477

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Fullerton, California, United States
View all 20 locations
View Trial Details

Related conditions